Bicara Therapeutics Inc. (BCAX) Reports Q2 Loss of $0.82

Go back to Bicara Therapeutics Inc. (BCAX) Reports Q2 Loss of $0.82
(NASDAQ: BCAX) Delayed: 24.63 +0.87 (3.66%)
Previous Close $23.76    52 Week High
Open $24.00    52 Week Low
Day High $25.14    P/E N/A 
Day Low $23.88    EPS
Volume 810,300